Innoviva Historical Income Statement

INVA Stock

USD 19.05 0.09 0.47%

Historical analysis of Innoviva income statement accounts such as Gross Profit of 274.1 M or Other Operating Expenses of 73.5 M can show how well Innoviva performed in making a profits. Evaluating Innoviva income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of Innoviva's future profits or losses.

Cash Flow Balance Sheet Income Statement

Housing Crash

Credit Downgrade

Yuan Drop

Covid

Financial Statement Analysis is much more than just reviewing and examining Innoviva latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Innoviva is a good buy for the upcoming year.

Net Income Gross Profit

Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Innoviva. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real.

For information on how to trade Innoviva Stock refer to our How to Trade Innoviva Stock guide.

About Innoviva Income Statement Analysis

Innoviva Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Innoviva shareholders. The income statement also shows Innoviva investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).

Innoviva Income Statement Chart

At present, Innoviva's Depreciation And Amortization is projected to increase significantly based on the last few years of reporting. The current year's Gross Profit is expected to grow to about 274.1 M, whereas Interest Expense is forecasted to decline to about 15.6 M.

Other Operating Expenses Total Operating Expenses Total Revenue Selling General Administrative

Other Operating Expenses

Other Operating Expenses is the expense which generally does not depend on sales or production quantities of Innoviva. It is also known as Innoviva overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. Expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production.

Total Operating Expenses

The total costs associated with the day-to-day operations of a business, excluding the cost of goods sold but including selling, general, and administrative expenses.

Total Revenue

Total revenue comprises all receipts Innoviva generated from the sale of its products or services. The total amount of income generated by the sale of goods or services related to the company's primary operations.

Most accounts from Innoviva's income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into Innoviva current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Innoviva. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real.

For information on how to trade Innoviva Stock refer to our How to Trade Innoviva Stock guide.At present, Innoviva's Depreciation And Amortization is projected to increase significantly based on the last few years of reporting. The current year's Gross Profit is expected to grow to about 274.1 M, whereas Interest Expense is forecasted to decline to about 15.6 M.

Innoviva income statement Correlations

	Depreciation And Amortization	Interest Expense	Gross Profit	Other Operating Expenses	Operating Income	Ebit	Research Development	Ebitda	Cost Of Revenue	Total Operating Expenses	Net Income	Income Tax Expense	Total Revenue	Selling General Administrative	Income Before Tax	Total Other Income Expense Net	Net Income From Continuing Ops	Non Operating Income Net Other	Discontinued Operations	Interest Income	Net Interest Income	Reconciled Depreciation	Minority Interest	Tax Provision
Depreciation And Amortization		0.05	0.51	0.01	0.42	0.48	-0.21	0.55	-0.21	0.03	0.45	0.04	0.57	0.82	0.43	0.25	0.16	0.77	0.88	-0.45	0.74	0.59	-0.1	0.54
Interest Expense	0.05		0.06	-0.64	0.2	0.14	-0.66	0.15	-0.58	-0.57	0.08	0.21	-0.04	-0.22	0.05	-0.27	0.13	-0.25	-0.11	-0.25	-0.2	-0.02	-0.1	-0.24
Gross Profit	0.51	0.06		-0.21	0.74	0.8	-0.33	0.79	-0.37	-0.16	0.77	-0.12	0.81	0.29	0.75	0.32	0.68	0.65	0.31	-0.71	0.72	0.09	0.29	0.59
Other Operating Expenses	0.01	-0.64	-0.21		-0.62	-0.52	0.91	-0.5	0.84	0.98	-0.46	-0.08	-0.33	0.53	-0.5	0.13	-0.6	0.04	0.27	0.53	-0.16	0.17	-0.49	-0.16
Operating Income	0.42	0.2	0.74	-0.62		0.98	-0.69	0.98	-0.71	-0.58	0.92	0.0	0.94	-0.05	0.98	0.34	0.92	0.61	0.16	-0.9	0.78	0.04	0.65	0.75
Ebit	0.48	0.14	0.8	-0.52	0.98		-0.62	0.99	-0.66	-0.48	0.91	0.04	0.96	0.07	0.99	0.47	0.9	0.7	0.22	-0.88	0.83	0.04	0.61	0.8
Research Development	-0.21	-0.66	-0.33	0.91	-0.69	-0.62		-0.62	0.96	0.91	-0.55	-0.12	-0.43	0.3	-0.59	0.0	-0.63	-0.14	0.03	0.63	-0.33	-0.01	-0.38	-0.29
Ebitda	0.55	0.15	0.79	-0.5	0.98	0.99	-0.62		-0.67	-0.46	0.92	0.02	0.97	0.14	0.98	0.43	0.88	0.72	0.28	-0.9	0.86	0.07	0.53	0.8
Cost Of Revenue	-0.21	-0.58	-0.37	0.84	-0.71	-0.66	0.96	-0.67		0.87	-0.61	-0.06	-0.48	0.27	-0.62	-0.08	-0.67	-0.18	0.06	0.66	-0.38	0.09	-0.32	-0.34
Total Operating Expenses	0.03	-0.57	-0.16	0.98	-0.58	-0.48	0.91	-0.46	0.87		-0.44	-0.07	-0.29	0.54	-0.47	0.1	-0.57	0.05	0.29	0.5	-0.14	0.21	-0.47	-0.15
Net Income	0.45	0.08	0.77	-0.46	0.92	0.91	-0.55	0.92	-0.61	-0.44		-0.36	0.91	0.07	0.9	0.24	0.93	0.54	0.23	-0.88	0.8	0.07	0.45	0.61
Income Tax Expense	0.04	0.21	-0.12	-0.08	0.0	0.04	-0.12	0.02	-0.06	-0.07	-0.36		-0.03	0.02	0.04	0.46	-0.24	0.27	-0.03	0.13	-0.05	-0.09	0.2	0.33
Total Revenue	0.57	-0.04	0.81	-0.33	0.94	0.96	-0.43	0.97	-0.48	-0.29	0.91	-0.03		0.23	0.97	0.46	0.83	0.78	0.35	-0.86	0.9	0.14	0.55	0.84
Selling General Administrative	0.82	-0.22	0.29	0.53	-0.05	0.07	0.3	0.14	0.27	0.54	0.07	0.02	0.23		0.03	0.23	-0.23	0.6	0.81	-0.07	0.47	0.48	-0.44	0.28
Income Before Tax	0.43	0.05	0.75	-0.5	0.98	0.99	-0.59	0.98	-0.62	-0.47	0.9	0.04	0.97	0.03		0.5	0.9	0.71	0.19	-0.86	0.83	0.02	0.68	0.83
Total Other Income Expense Net	0.25	-0.27	0.32	0.13	0.34	0.47	0.0	0.43	-0.08	0.1	0.24	0.46	0.46	0.23	0.5		0.28	0.7	0.11	-0.2	0.46	-0.15	0.45	0.71
Net Income From Continuing Ops	0.16	0.13	0.68	-0.6	0.92	0.9	-0.63	0.88	-0.67	-0.57	0.93	-0.24	0.83	-0.23	0.9	0.28		0.39	-0.08	-0.83	0.65	-0.14	0.63	0.57
Non Operating Income Net Other	0.77	-0.25	0.65	0.04	0.61	0.7	-0.14	0.72	-0.18	0.05	0.54	0.27	0.78	0.6	0.71	0.7	0.39		0.63	-0.52	0.89	0.31	0.36	0.92
Discontinued Operations	0.88	-0.11	0.31	0.27	0.16	0.22	0.03	0.28	0.06	0.29	0.23	-0.03	0.35	0.81	0.19	0.11	-0.08	0.63		-0.18	0.56	0.87	-0.17	0.36
Interest Income	-0.45	-0.25	-0.71	0.53	-0.9	-0.88	0.63	-0.9	0.66	0.5	-0.88	0.13	-0.86	-0.07	-0.86	-0.2	-0.83	-0.52	-0.18		-0.72	-0.04	-0.42	-0.61
Net Interest Income	0.74	-0.2	0.72	-0.16	0.78	0.83	-0.33	0.86	-0.38	-0.14	0.8	-0.05	0.9	0.47	0.83	0.46	0.65	0.89	0.56	-0.72		0.28	0.37	0.88
Reconciled Depreciation	0.59	-0.02	0.09	0.17	0.04	0.04	-0.01	0.07	0.09	0.21	0.07	-0.09	0.14	0.48	0.02	-0.15	-0.14	0.31	0.87	-0.04	0.28		-0.07	0.12
Minority Interest	-0.1	-0.1	0.29	-0.49	0.65	0.61	-0.38	0.53	-0.32	-0.47	0.45	0.2	0.55	-0.44	0.68	0.45	0.63	0.36	-0.17	-0.42	0.37	-0.07		0.58
Tax Provision	0.54	-0.24	0.59	-0.16	0.75	0.8	-0.29	0.8	-0.34	-0.15	0.61	0.33	0.84	0.28	0.83	0.71	0.57	0.92	0.36	-0.61	0.88	0.12	0.58

Click cells to compare fundamentals

Innoviva Account Relationship Matchups

Innoviva income statement Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Depreciation And Amortization	13.9M	13.8M	13.8M	19.5M	35.7M	37.5M
Interest Expense	18.7M	18.3M	19.1M	15.8M	19.2M	15.6M
Gross Profit	261.0M	336.8K	391.9M	317.5M	261.1M	274.1M
Other Operating Expenses	14.7M	15.7M	16.8M	124.3M	133.8M	73.5M
Operating Income	246.4M	321.1M	375.1M	210.0M	176.7M	185.5M
Ebit	217.9M	303.2M	426.2M	302.7M	213.3M	223.9M
Research Development	559K	1.8M	576K	41.4M	33.9M	48.3M
Ebitda	231.7M	317.0M	361.4M	322.3M	249.0M	261.4M
Total Operating Expenses	14.7M	15.7M	16.8M	110.6M	132.2M	71.6M
Net Income	157.3M	224.4M	265.9M	213.9M	179.7M	188.7M
Income Tax Expense	41.9M	60.4M	76.4M	66.7M	14.4M	19.4M
Total Revenue	261.0M	336.8M	391.9M	331.3M	310.5M	326.0M
Selling General Administrative	14.7M	13.9M	16.2M	63.5M	89.4M	93.8M
Income Before Tax	232.9M	354.2M	445.3M	286.9M	194.1M	203.8M
Total Other Income Expense Net	(13.5M)	33.1M	70.2M	77.0M	17.4M	18.3M
Net Income From Continuing Ops	191.0M	293.8M	368.8M	220.3M	49.9M	47.4M
Non Operating Income Net Other	(5.7M)	(4.0M)	51.5M	87.4M	100.5M	105.5M
Net Income Applicable To Common Shares	157.3M	224.4M	265.9M	213.9M	246.0M	258.3M
Interest Income	5.5M	1.5M	1.8M	6.4M	14.2M	7.5M
Net Interest Income	(13.1M)	(16.8M)	(17.2M)	(9.4M)	(3.0M)	(3.2M)
Reconciled Depreciation	13.9M	13.8M	13.8M	5.6M	33.3M	17.0M
Minority Interest	11.3M	33.7M	69.4M	103.0M	(6.3M)	0.0
Tax Provision	41.9M	60.4M	76.4M	66.7M	18.3M	12.4M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

ESRT	Empire State Realty
C	Citigroup
C	Citigroup

When determining whether Innoviva offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Innoviva's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Innoviva Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Innoviva Stock:

How To Invest In Innoviva

Details

Is Innoviva Stock a good investment?

Details

What is Innoviva's Net Worth?

Details

Largest Pharmaceuticals Companies

View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies

View

For information on how to trade Innoviva Stock refer to our How to Trade Innoviva Stock guide.

You can also try the Sectors module to list of equity sectors categorizing publicly traded companies based on their primary business activities.

Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Innoviva. If investors know Innoviva will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Innoviva listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Quarterly Earnings Growth

(0.98)

Earnings Share

0.8

Revenue Per Share

5.6

Quarterly Revenue Growth

0.331

Return On Assets

0.0937

The market value of Innoviva is measured differently than its book value, which is the value of Innoviva that is recorded on the company's balance sheet. Investors also form their own opinion of Innoviva's value that differs from its market value or its book value, called intrinsic value, which is Innoviva's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Innoviva's market value can be influenced by many factors that don't directly affect Innoviva's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Innoviva's value and its price as these two are different measures arrived at by different means. Investors typically determine if Innoviva is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Innoviva's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Innoviva Historical Income Statement

About Innoviva Income Statement Analysis

Innoviva Income Statement Chart

Other Operating Expenses

Total Operating Expenses

Total Revenue

Innoviva income statement Correlations

Innoviva Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Innoviva income statement Accounts

Also Currently Popular

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Ebitda	+ 0.99	Ebit
Income Before Tax	+ 0.99	Ebit
Total Operating Expenses	+ 0.98	Other Operating Expenses
Ebit	+ 0.98	Operating Income
Ebitda	+ 0.98	Operating Income
Income Before Tax	+ 0.98	Operating Income

Interest Income	- 0.9	Ebitda
Interest Income	- 0.9	Operating Income
Interest Income	- 0.88	Net Income
Interest Income	- 0.88	Ebit
Interest Income	- 0.86	Income Before Tax
Interest Income	- 0.86	Total Revenue